Main content

    Biliary Cancer Clinical Trials

    Oncology / Cancer Clinical Trials Main Page | Adult Clinical Trials Main Page

    Further protocol information can be found on the links below at

    Active Trials

    Title: Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma
    Description: This randomized phase III trial studies how well gemcitabine hydrochloride and cisplatin with or without radiation therapy work in treating patients with localized liver cancer that cannot be removed by surgery
    Investigator: NCI - National Cancer Institute
    Eligibility: Subjects, 18 y/o and older, with a pathologically (histologically or cytologically) proven diagnosis of intrahepatic cholangiocarcinoma (IHC) without distant extrahepatic metastasis within 30 days of registration
    Status: Please contact site for study status
    Contact: Brenda Eng, 415-600-1775, about Study NRG-GI001

    Title: A Phase 2, Open-Label, Single Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed or Are Intolerant to Platinum-Based Chemotherapy
    Description: This is an open-label, monotherapy study of INCB054828 in subjects with advanced/metastatic or surgically unresectable cholangiocarcinoma with FGFR2 translocations, with other FGF/FGFR alterations, or who are negative for FGF/FGFR alterations
    Investigator: Ari Baron, MD
    Eligibility: Subjects, 18 y/o and older, with a histologically or cytologically confirmed cholangiocarcinoma
    Status: Open to enrollment
    Contact: Brenda Eng, 415-600-1775, Email: about Study INCB 54828-202

    • updated 03/2018

    Back to top